ATE502935T1 - C-met-proteinkinasehemmer - Google Patents

C-met-proteinkinasehemmer

Info

Publication number
ATE502935T1
ATE502935T1 AT08835773T AT08835773T ATE502935T1 AT E502935 T1 ATE502935 T1 AT E502935T1 AT 08835773 T AT08835773 T AT 08835773T AT 08835773 T AT08835773 T AT 08835773T AT E502935 T1 ATE502935 T1 AT E502935T1
Authority
AT
Austria
Prior art keywords
protein kinase
met protein
kinase inhibitors
compounds
compositions
Prior art date
Application number
AT08835773T
Other languages
English (en)
Inventor
David Lauffer
Pan Li
Nathan Waal
Kira Mcginty
Qing Tang
Steven Ronkin
Luc Farmer
Dean Shannon
Dylan Jacobs
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Application granted granted Critical
Publication of ATE502935T1 publication Critical patent/ATE502935T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
AT08835773T 2007-10-03 2008-09-30 C-met-proteinkinasehemmer ATE502935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97730507P 2007-10-03 2007-10-03
PCT/US2008/078239 WO2009045992A2 (en) 2007-10-03 2008-09-30 C-met protein kinase inhibitors

Publications (1)

Publication Number Publication Date
ATE502935T1 true ATE502935T1 (de) 2011-04-15

Family

ID=40512401

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08835773T ATE502935T1 (de) 2007-10-03 2008-09-30 C-met-proteinkinasehemmer

Country Status (12)

Country Link
US (1) US8481524B2 (de)
EP (1) EP2205589B1 (de)
JP (1) JP2010540649A (de)
CN (1) CN101990538A (de)
AT (1) ATE502935T1 (de)
AU (1) AU2008308900A1 (de)
CA (1) CA2701124A1 (de)
DE (1) DE602008005786D1 (de)
ES (1) ES2361650T3 (de)
MX (1) MX2010003563A (de)
NZ (1) NZ584311A (de)
WO (1) WO2009045992A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2350045A1 (de) * 2008-10-21 2011-08-03 Vertex Pharmaceuticals Incorporated Inhibitoren von c-met-proteinkinase
EP2521450B1 (de) 2010-01-07 2015-02-25 E.I. Du Pont De Nemours And Company Fungizide heterocyclische verbindungen
US20130315895A1 (en) 2010-07-01 2013-11-28 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
KR101716993B1 (ko) 2012-12-25 2017-03-15 닛뽕소다 가부시키가이샤 할로겐화 아닐린 및 그 제조 방법
CN103242216A (zh) * 2013-05-07 2013-08-14 兰州梦唐精细化工有限公司 N- Boc -六氢-5-氧代环戊[C]并吡咯的合成方法
US9896436B2 (en) 2014-09-16 2018-02-20 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
ES2911292T3 (es) 2014-09-16 2022-05-18 Celgene Quanticel Res Inc Inhibidores de desmetilasas de histonas
EP3229836B1 (de) 2014-12-09 2019-11-13 Institut National de la Sante et de la Recherche Medicale (INSERM) Menschliche monoklonale antikörper gegen axl
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169800B2 (en) * 2003-09-24 2007-01-30 Vertex Pharmaceuticals Incorporated Imidazole compositions useful as inhibitors of protein kinases
US7169781B2 (en) * 2003-10-17 2007-01-30 Hoffmann-La Roche Inc. Imidazole derivatives and their use as pharmaceutical agents
DE602007004092D1 (de) * 2006-03-22 2010-02-11 Vertex Pharma C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen

Also Published As

Publication number Publication date
ES2361650T3 (es) 2011-06-21
WO2009045992A3 (en) 2009-06-04
US8481524B2 (en) 2013-07-09
WO2009045992A2 (en) 2009-04-09
NZ584311A (en) 2012-03-30
EP2205589B1 (de) 2011-03-23
AU2008308900A1 (en) 2009-04-09
JP2010540649A (ja) 2010-12-24
EP2205589A2 (de) 2010-07-14
MX2010003563A (es) 2010-06-02
CA2701124A1 (en) 2009-04-09
CN101990538A (zh) 2011-03-23
US20110136789A1 (en) 2011-06-09
DE602008005786D1 (de) 2011-05-05

Similar Documents

Publication Publication Date Title
NO20084435L (no) C-MET proteinkinaseinhibitorer
ATE502935T1 (de) C-met-proteinkinasehemmer
MX2009009590A (es) Aminopirimidinas utiles como inhibidores de proteinas cinasas.
IL200793A0 (en) Aminopyrimidines, compositions comprising the same and use thereof for inhibiting protein kinases
NO20082508L (no) Aminopyrimidiner anvendelige som kinaseinhibitorer
ATE530540T1 (de) Pyrimidonverbindungen als gsk-3-inhibitoren
EA201390803A1 (ru) Ингибиторы бромодомена и их применение
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
MX2009008253A (es) Derivados de 2-aminopiridina utiles como inhibidores de cinasa.
MX2009010037A (es) Aminopirimidinas utiles como inhibidores de cinasas.
EA201200049A1 (ru) 1,3-дизамещенные производные имидазолидин-2-она в качестве ингибиторов cyp 17
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
EA201100580A1 (ru) Имидазопиридазинкарбонитрилы, используемые в качестве ингибиторов киназы
EA201000094A1 (ru) Производные пиримидинил-пиридазинона
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
MX2009009592A (es) Aminopiridinas utiles como inhibidores de proteinas cinasas.
NO20072567L (no) Triazoler nyttige som proteinkinase-inhibitorer
MX2009011810A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
EA201170052A1 (ru) Производные тиофена или тиазола и их применение как ингибиторов pi3k
MX2009011811A (es) Aminopirimidinas utiles como inhibidores de cinasa.
MX2009012719A (es) Tiazoles y pirazoles utiles como inhibidores de cinasa.
MX2009006345A (es) Compuestos utiles como inhibidores de proteina cinasa.
MX2009002842A (es) Inhibidores heterociclicos de c-met y usos de los mismos.
ATE542814T1 (de) Pyrazinkinaseinhibitoren
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties